A key session at the Cell & Gene Therapy World Conference 2025 will address the pressing manufacturing challenges in scaling up cell and gene therapies. Discussions will center on ensuring product consistency, optimizing production costs, navigating supply chain hurdles, and meeting stringent regulatory requirements. With a focus on global accessibility, this session aims to advance strategies for efficient and scalable manufacturing, making transformative therapies more accessible to patients worldwide.